The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Size Of The Yellow Fever Vaccine Market Progress Through 2030?
The yellow fever vaccine market has experienced consistent growth in recent times. It will grow from $4.74 billion in 2025 to $4.97 billion in 2026 at a compound annual growth rate (CAGR) of 4.8%. Factors contributing to this historical growth include repeated yellow fever outbreaks, government-mandated immunization programs, established vaccine effectiveness, international travel regulations, and various public health initiatives.
The yellow fever vaccine market is projected to observe consistent expansion over the coming years. Its valuation is forecast to reach $5.88 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 4.3%. The drivers behind this growth within the forecast timeframe include the climate-induced spread of mosquitoes, an uptick in global travel, the enhancement of vaccination infrastructure, increased funding allocated to disease prevention, and strengthened preparedness for outbreaks. Significant trends anticipated during this period encompass the broadening of routine immunization initiatives, escalating demand from international travelers, more extensive government-led vaccination campaigns, the increasing adoption of single-dose vaccines, and a concentrated effort on preventing endemic diseases.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp
What Primary Factors Are Fueling The Expansion Of The Yellow Fever Vaccine Market?
The yellow fever vaccine market is projected to expand as a result of the rising volume of international travel. This travel involves individuals crossing national boundaries for tourism, business, or personal reasons. Global mobility is increasing, driving this surge in international travel, which is further aided by economic improvements and the relaxation of post-pandemic travel limitations. The yellow fever vaccine market caters to travelers by offering essential or suggested immunizations required for entry into areas where the disease is prevalent. As an illustration, figures from January 2024, released by the World Tourism Organization (UNWTO), an international tourism agency located in Spain, indicated that worldwide international tourist arrivals totaled 1.286 billion in 2023. This marks an increase from 0.96 billion in 2022, signifying a year-on-year rise of 0.326 billion international tourists. Consequently, the expansion of international travel is a key factor propelling the yellow fever vaccine market’s growth.
Which Segment Divisions Form The Structure Of The Yellow Fever Vaccine Market?
The yellow fever vaccine market covered in this report is segmented –
1) By Product: Powder, Liquid
2) By Application: Routine Immunization, Travelers, Other Applications
3) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users
Subsegments:
1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution
2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes
What Trends Are Shaping The Yellow Fever Vaccine Market Structure?
Leading companies in the yellow fever vaccine market are increasingly directing their efforts toward developing innovative solutions, such as T-cell adaptive booster vaccines, with the goal of enhancing long-term immunity, improving vaccine efficacy, and addressing the limitations inherent in traditional live-attenuated vaccines. T-cell adaptive booster vaccines are designed to bolster the immune system through the specific amplification of T-cell responses, which enables the body to recognize and fight infections more effectively compared to conventional antibody-focused vaccines. For example, in April 2025, the All India Institute of Medical Sciences, an India-based healthcare institute, introduced Yellow Fever Vaccination services. These services aim to provide travelers with protection against the mosquito-borne viral disease and to issue the globally recognized vaccination certificate. The initiative is intended to increase the accessibility of the vaccine within Telangana, thereby reducing the need for individuals to travel long distances to other authorized centers. Additionally, the program ensures strict adherence to international health regulations by providing safe administration under medical supervision, particularly for individuals who have contraindications.
Who Are The Leading Firms Participating In The Yellow Fever Vaccine Market?
Major companies operating in the yellow fever vaccine market are Sanofi S.A., Bio-Manguinhos, Institut Pasteur de Dakar, Instituto Butantan, Bio Farma, Biological E. Limited, Beijing Tiantan Biological Products Co. Ltd., Wuhan Institute of Biological Products, Merck & Co. Inc., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Lonza Group AG, WuXi Biologics, Ology Bioservices, Valneva SE, Bavarian Nordic A/S, Panacea Biotec Ltd., Biovac, Novavax Inc., PnuVax Incorporated
Access The Complete Yellow Fever Vaccine Market Report:
https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report
What Is The Largest Regional Market In The Yellow Fever Vaccine Market?
North America was the largest region in the yellow fever vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Yellow Fever Vaccine Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp
Browse Through More Reports Similar to the Global Yellow Fever Vaccine Market 2026, By The Business Research Company
Yellow Fever Vaccine Market Report 2026
https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report
Yellow Fever Vaccine Market Report 2026
https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report
Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model